$BIO Bio Protocol's native token, BIO, was recently listed on Binance, marking a significant milestone for the decentralized science (DeSci) project. The listing occurred on January 3, 2025, with trading pairs including BIO/USDT, BIO/BNB, BIO/FDUSD, and BIO/TRY. Following the listing, BIO experienced a remarkable surge, briefly reaching a market capitalization of $1.1 billion and an intraday high of $1.47.
BIO Protocol aims to revolutionize scientific research funding by leveraging blockchain technology to create a decentralized ecosystem for biotechnology. The project was founded by the teams behind Molecule, a tokenization platform for biomedicine, and VitaDAO, a decentralized organization focused on science. At the core of Bio Protocol are BioDAOs (Decentralized Autonomous Organizations), which enable community-driven funding and ownership of scientific projects. These BioDAOs allow patients, scientists, and professionals in the biotechnology sector to collectively finance and own the intellectual property of groundbreaking research.
The BIO token serves multiple purposes within the ecosystem, including governance rights, whitelist access to BioDAO financing rounds, and curatorial management of BioDAOs. Holders can stake their BIO tokens to vote on which new BioDAOs should join the ecosystem, receiving exclusive benefits such as early token sales or privileged access to biomedical research. The project has garnered support from prominent venture capital firms, including 1kx Network, Fifty Years Venture Capital, Binance Labs, and Northpond Ventures.
As of now, BIO is trading at approximately $0.7314 USD, with an intraday high of $0.78699 and a low of $0.674893.
#BIO #BİO #biousdt #qaswar_crypto